Page 551 - Fluid, Electrolyte, and Acid-Base Disorders in Small Animal Practice
P. 551
Fluid and Diuretic Therapy in Heart Failure 539
7. Atkins C, Bonagura J, Ettinger S, Fox P, Gordon S, In: McCall D, Rahimtoola SH, editors. Heart failure.
Haggstrom J, et al. Guidelines for the diagnosis and treat- New York: Chapman & Hall; 1995. p. 316–44.
ment of canine chronic valvular heart disease. J Vet Intern 27. Creager MA, Halperin JL, Bernard DB, et al. Acute
Med 2009;23(6):1142–50. regional circulatory and renal hemodynamic effects of
8. Auld RB, Alexander EA, Levinsky NG. Proximal tubular converting-enzyme inhibition in patients with congestive
function in dogs with thoracic caval constriction. J Clin heart failure. Circulation 1981;64:483–9.
Invest 1971;50:2150–8. 28. Decarli C, Spouse G, Larosa JL. Serum magnesium levels
9. Barger AC, Yates FE, Rudolph AM. Renal hemodynamics in symptomatic atrial fibrillation and their relation to
and sodium excretion in dogs with graded valvular dam- rhythm control by intravenous digoxin. Am J Cardiol
age, and in congestive failure. Am J Physiol 1986;57:956–9.
1961;200:601–8. 29. DeFrancesco TC, Rush JE, Rozanski EA, Hansen BD,
10. Bernay F, Bland JM, Ha ¨ggstro ¨m J, Baduel L, Combes B, Keene BW, Moore DT, et al. Prospective clinical evalua-
Lopez A, et al. Efficacy of spironolactone on survival in tion of an ELISA B-type natriuretic peptide assay in the
dogs with naturally occurring mitral regurgitation caused diagnosis of congestive heart failure in dogs presenting
by myxomatous mitral valve disease. J Vet Intern Med with cough or dyspnea. J Vet Intern Med 2007;21
2010;24(2):331–41(also see Letter to Editor:J Vet Intern (2):243–50.
Med 2010; in press. 30. Dirks JH, Cirksena WJ, Berliner RW. Micropuncture
11. Bonagura JD, Lehmkuhl LB. Fluid therapy in heart fail- study of the effect of various diuretics on sodium reab-
ure. In: DiBartola SJ, editor. Fluid therapy in small animal sorption by the proximal tubules of the dog. J Clin Invest
practice. 1st ed Philadelphia: WB Saunders; 1992. 1966;45:1875–85.
p. 529–53. 31. Dormans TP, Pickkers P, Russel FG, et al. Vascular effects
12. Bonagura JD, Ware WA. Atrial fibrillation in the dog: of loop diuretics. Cardiovasc Res 1996;32:988–97.
clinical findings in 81 cases. J Am Anim Hosp Assoc 32. Dormans TP, van Meyel JJ, Gerlag PG, et al. Diuretic effi-
1986;22:111–20. cacy of high dose furosemide in severe heart failure: bolus
13. Bourland WA, Day DK, Williams HE. The role of the kid- injection versus continuous infusion. J Am Coll Cardiol
ney in the early nondiuretic action of furosemide to reduce 1996;28:376–82.
elevated left atrial pressure in the hypervolemic dog. 33. Dow SJ, Fettman MJ, Smith KR, et al. Taurine depletion
J Pharmacol Exp Ther 1977;202:221–9. and cardiovascular disease in adult cats fed a potassium-
14. Bristow MR. Mechanism of action of beta-blocking agents depleted acidified diet. Am J Vet Res 1992;53:402–5.
in heart failure. Am J Cardiol 1997;80:26L–40L. 34. Dumont AE, Clauss RH, Reed GE, et al. Lymph drainage
15. Calvert CA, Rawlings CA. Canine heartworm disease. in patients with congestive heart failure: comparison with
In: Fox PR, editor. Canine and feline cardiology. New findings in hepatic cirrhosis. N Engl J Med
York: Churchill Livingstone; 1988. p. 519–49. 1963;269:949–52.
16. Cannon PJ. The kidney in heart failure. N Engl J Med 35. Dzau VJ, Hollenberg NK. Renal response to captopril in
1977;296:26–32. severe heart failure: role of furosemide in natriuresis
17. Cataliotti A, Boerrigter G, Costello-Boerrigter LC, et al. and reversal of hyponatremia. Ann Intern Med
Brain natriuretic peptide enhances renal actions of furose- 1984;100:777–81.
mide and suppresses furosemide-induced aldosterone 36. Dzau VJ, Swartz SL. Dissociation of the prostaglandin
activation in experimental heart failure. Circulation and renin-angiotensin systems during captopril therapy
2004;109:1680–5. for chronic congestive heart failure secondary to coronary
18. Chen HH, Grantham JA, Schirger JA, et al. Subcutaneous artery disease. Am J Cardiol 1987;60:1101–5.
administration of brain natriuretic peptide in experimental 37. Dzau VJ, Colucci WS, Hollenberg NK, et al. Relation of
heart failure. J Am Coll Cardiol 2000;36:1706–12. the renin-angiotensin-aldosterone system to clinical state
19. Clark AL, Poole-Wilson PA, Coats AJ. Exercise limitation in congestive heart failure. Circulation 1981;63:645–51.
in chronic heart failure: central role of the periphery. J Am 38. Dzau VJ, Packer M, Lilly LS, et al. Prostaglandins in severe
Coll Cardiol 1996;28:1092–102. congestive heart failure: relation to activation of the
20. Cobb M, Michell AR. Plasma electrolyte concentrations in renin-angiotensin system and hyponatremia. N Engl J
dogs receiving diuretic therapy for cardiac failure. J Small Med 1984;310:347–52.
Anim Pract 1992;33:526–9. 39. Eaton GE, Cody RJ, Brinkley PF. Increase in aortic
21. Cogan MG. Atrial natriuretic peptide. Kidney Int impedance precedes peripheral vasoconstriction at the
1990;37:1148–60. early stage of ventricular failure in the paced canine model.
22. Cohn JN, Levine TB. Angiotensin-converting enzyme Circulation 1993;88:2714–21.
inhibition in congestive heart failure: the concept. Am J 40. Edwards JN. Magnesium and congestive heart failure,
Cardiol 1982;49:1480–3. In: Proceedings of the American College of Veterinary
23. Cohn JN, Levine TB, Olivar MT, et al. Plasma norepi- Internal Medicine; 1991. p. 679–80 New Orleans.
nephrine as a guide to prognosis in patients with chronic 41. Fenelon G, Protter AA, Stambler BS. Examination of the
congestive heart failure. N Engl J Med 1984;311:819–23. in vivo cardiac electrophysiological effects of nesiritide
24. Connolly DJ. Natriuretic peptides: the feline experience. (human brain natriuretic peptide) in conscious dogs.
Vet Clin North Am Small Anim Pract 2010;40 J Card Fail 2002;8:320–5.
(4):559–70. 42. Feuerstein GZ, Yue TL, Cheng HY, et al. Myocardial pro-
25. Co-operative Veterinary Enalapril (COVE) Study Group . tection by the novel vasodilating beta-blocker, carvedilol:
Controlled clinical evaluation of enalapril in dogs with potential relevance of anti-oxidant activity. J Hypertens
heart failure-results of the cooperative veterinary enalapril Suppl 1993;11:S41–S48.
study group. J Vet Intern Med 1995;9:243–52. 43. Fichman MP, Vorherr H, Kleeman CR, et al. Diuretic-
26. Creager MA, Cusco JA. Treatment of congestive heart induced hyponatremia. Ann Intern Med
failure with angiotensin-converting enzyme inhibitors. 1971;75:853–63.